iTherx Pharmaceuticals Obtains $3,173,595 New Funding Round

  • Feed Type
  • Date
    11/7/2011
  • Company Name
    iTherx Pharmaceuticals
  • Mailing Address
    14090 Caminito Vistana San Diego, CA 92130
  • Company Description
    iTherX is a clinical stage pharmaceutical company focused on the discovery and development of innovative treatments for Hepatitis C. This is a disease that affects almost 3% of the world’s population, and is the major cause of chronic liver disease, cirrhosis, liver failure and primary liver cancer.
  • Website
    http://www.itherx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,173,595
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed